Plain-English translation of NCT06514573 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether sodium butyrate, a natural compound that may help support gut health, can improve digestive problems and behavioral symptoms in young children with autism spectrum disorder. Half of the children will receive the medication daily, and half will receive a placebo (a dummy treatment that looks identical). All children will continue their regular autism care.
Many children with autism also struggle with digestive problems that can make their behavior and sleep worse. Doctors believe that this medication may help by supporting the gut's natural bacteria and reducing inflammation, but this hasn't been proven yet in children with autism.
You likely qualify if…
You likely don't qualify if…
Your child will take a daily powder supplement (either the medication or placebo) mixed in a sachet at home, based on their body weight. You'll also bring your child to visits at one of the study centers so doctors can check on their digestive and behavioral symptoms. The study will track how your child responds over time while continuing all their regular autism treatments and care.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
Italy